MariMed Inc. (MRMD)

Stock Price Forecast

According to 8 stock analysts, the average 12-month stock price forecast for MariMed stock is $1.28, which predicts an increase of 178.26%. The lowest target is $1.01 and the highest is $1.58. On average, analysts rate MariMed stock as a buy.

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$1.01	$1.28	$1.28	$1.58
Change	+119.57%	+178.26%	+178.26%	+243.48%

Analyst Ratings

The average analyst rating for MariMed stock from 8 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jan '22	Feb '22	Mar '22	Apr '22	May '22	Jun '22
Strong Buy	3	3	3	3	2	2
Buy	4	4	4	5	5	5
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	8	8	8	9	8	8

Financial Forecast

Revenue This Year

145.81M

from 121.46M

Increased by 20.04%

from 121.46M

Revenue Next Year

172.79M

from 145.81M

Increased by 18.50%

from 145.81M

EPS This Year

0.05

from 0.02

Increased by 116.93%

from 0.02

EPS Next Year

0.08

from 0.05

Increased by 60.00%

from 0.05

Year	2017	2018	2019	2020	2021	2022	2023	2024	2025
Revenue	6.07M	11.85M	45.60M	50.90M	121.46M	145.81M	172.79M	201.91M	240.66M
Revenue Growth	70.25%	95.32%	284.79%	11.60%	138.66%	20.04%	18.50%	16.85%	19.19%
EPS	-0.01	-0.07	-0.39	0.01	0.02	0.05	0.08	0.11	0.15
EPS Growth	-	-	-	-	135.10%	116.93%	60.00%	32.90%	35.56%
No. Analysts	-	-	-	-	-	3	3	1	1

Revenue Forecast

Revenue	2022	2023	2024	2025
High	152.4M	177.9M	212.0M	250.3M
Avg	145.8M	172.8M	201.9M	240.7M
Low	138.0M	166.0M	195.9M	233.4M

Revenue Growth

Revenue Growth	2022	2023	2024	2025
High	25.3%	22.0%	22.7%	24.0%
Avg	19.9%	18.5%	16.9%	19.2%
Low	13.4%	13.9%	13.3%	15.6%

EPS Forecast

EPS	2022	2023	2024	2025
High	0.05	0.08	0.11	0.15
Avg	0.05	0.08	0.11	0.15
Low	0.05	0.08	0.11	0.14

EPS Growth

EPS Growth	2022	2023	2024	2025
High	14.4%	64.7%	39.5%	41.0%
Avg	11.1%	60.0%	32.9%	35.6%
Low	6.8%	53.7%	28.9%	31.5%